Kronox Lab Sciences
NSE: KRONOX · ISIN INE0ATZ01017 · Basic Materials
₹190.25+1.15 (+0.61%)
Monday 9 November, 11:59 IST. Delayed. Source: Yahoo Finance.
Price chart
₹190.25 +1.15 (+0.61%) today
The day
- Previous close
- ₹189.10
- Open
- ₹192.45
- Day high
- ₹192.45
- Day low
- ₹187.05
Listed on NSE since 10 June 2024.
Key numbers
- Market value
- ₹704.98 Cr
- P/E (trailing)
- 23.93
- EPS (trailing)
- ₹7.94
- Price to book
- 6.07
- Dividend yield
- 0.26%
- Debt to equity
- 0.01
- Profit margin
- 27.2%
- Beta
- 0.97
- Volume today
- 10,421
- Average volume
- 6.65 L
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹95.58 Cr | ₹16.62 Cr |
| FY24 | ₹89.86 Cr | ₹21.35 Cr |
| FY25 | ₹100.19 Cr | ₹25.47 Cr |
| FY26 | ₹101.22 Cr | ₹27.66 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹55 Cr | ₹14 Cr | +105.9% |
| Q1 FY27Apr–Jun 2026 | ₹28 Cr | ₹7 Cr | +16.3% |
| Q4 FY26Jan–Mar 2026Audited | ₹26 Cr | ₹8 Cr | +26.7% |
| Q3 FY26Oct–Dec 2025 | ₹25 Cr | ₹7 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹26 Cr | ₹7 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹24 Cr | ₹6 Cr | – |
Source: Kronox Lab Sciences’s results filed with NSE, standalone (the company alone). Net profit is the share of Kronox Lab Sciences’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 | March 2026 |
|---|---|---|
| Fixed assets | ₹30 Cr | ₹30 Cr |
| Investments | ₹0 | ₹2.50 L |
| Inventories | ₹7 Cr | ₹8 Cr |
| Owed by customers | ₹19 Cr | ₹21 Cr |
| Cash and equivalents | ₹9 Cr | ₹3 Cr |
| Total assets | ₹138 Cr | ₹128 Cr |
| Borrowings | ₹0 | ₹2 Cr |
| Total liabilities | ₹10 Cr | ₹11 Cr |
| Shareholders’ equity | ₹128 Cr | ₹116 Cr |
Source: Kronox Lab Sciences’s half-yearly statements of assets and liabilities filed with NSE, standalone. Companies file these every September and March.
About Kronox Lab Sciences
Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents comprising ACS reagents, as well as LR, AR, and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health; and specialty chemicals, such as tartrates, citrates, hypophosphites, phosphates, hydroxides, EDTA and derivatives, ultra high purity chemicals, and custom specification. Kronox Lab Sciences Limited was incorporated in 2008 and is based in Vadodara, India. As of September 29, 2026, Kronox Lab Sciences Limited operates as a subsidiary of Indo Borax & Chemicals Limited.
- Industry
- Specialty Chemicals
- Based in
- Vadodara
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Kronox Lab Sciences in the last day or two.
Dividends and corporate actions
All companies- Dividend - Re 0.50 Per Share
Dividend · ex-date 9 September 2026
- Dividend - Rs 0.50 Per Share
Dividend · ex-date 8 August 2025
- Annual General Meeting/Dividend - Re 0.50 Per Share
Dividend · ex-date 23 August 2024
Source: NSE. Latest first.
Information only, not investment advice. Prices are delayed.